The global biostimulants market is on a robust growth trajectory according to MRFR. In its 2025-dated report, MRFR estimates the market size at USD 3.85 billion in 2023, rising to USD 3331.92 Billion by 2024, and projects it will reach USD 14330.77 Billion, at a compound annual growth rate (CAGR) of approximately 8.28% over the 2025-2035 period.

These differing numbers highlight how the market’s growth expectations have been revised upward—reflecting stronger demand and favorable market conditions. For a stakeholder, this has major implications: a market that doubles or more in size offers many opportunities—but one must assess the time-horizon and growth assumptions carefully.

Drivers of growth include increasing adoption of sustainable agriculture, rising demand for high-value crops, greater focus on reducing reliance on chemical fertilizers, and favourable government initiatives for bio-inputs. According to MRFR, “the high demand for high-value crops and organic agriculture along with government initiatives …” are major growth drivers.

From a strategic viewpoint, growth means businesses along the value chain—from product manufacturers to distributors and applicators—should prepare for scale-up: invest in R&D, scale manufacturing capacity, strengthen distribution in emerging geographies, and engage in partnerships. The early growth phases of such markets often allow agile companies to capture market share and build brand recognition.
In conclusion, the biostimulants market is growing strongly—whether one uses the ~8% CAGR through 2035 or the ~12% through 2032—either way, the message is clear: this is a growth market, and participants must act early to harness the upside.